TABLE 4.
A2 assay | mALX4 presence | mALX4 absence |
---|---|---|
Sensitivity | 82.7% (62/75) | 74.7% (56/75) |
Specificity | 90.1% (154/171) | 95.3% (163/171) |
PL detection | 55.0% (22/40) | 50.0% (20/40) |
Accuracy | 87.8% (216/246) | 89.0% (219/246) |
Abbreviation: PL, precancerous lesions.